drugset / Trial / NCT04975724
Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if Liposom Forte will enhance the response to antidepressant therapy with citalopram in elderly patients suffering from Major Depressive Disorder (MDD).
Timeline
- Start
- 2019-04-18
- Primary completion
- 2025-10
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liposom Forte | Other / unclassified | 28 mg | Other |
| Background | Citalopram | Small molecule | 10 mg | — |